Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01208051
Title Cediranib Maleate With or Without Lenalidomide in Treating Patients With Thyroid Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

thyroid gland carcinoma

Therapies

Cediranib + Lenalidomide

Cediranib

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.